A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration with Toray Industries, Inc. is Caprin-1, a novel cancer target discovered by Toray. The ...

After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

A collaborative research team led by Professor Jinah Jang from the Department of Mechanical Engineering and the Department of ...

At Texas A&M University, one research lab is changing the game of droplet microfluidics, a technique that involves conducting ...

Five years since it launched, advances powered by the National Drug Discovery Centre are helping transform medical research in Australia and fast-tracking development of new home-grown treatments.

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism ...

Scientists have successfully developed a gastric cancer model using 3D bioprinting technology and patient-derived cancer tissue fragments. This innovative model preserves the characteristics of actual ...